Cargando…
The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo
[Image: see text] Lipid nanoparticles (LNPs) have delivered RNA to hepatocytes in patients, underscoring the potential impact of nonliver delivery. Scientists can shift LNP tropism to the lung by adding cationic helper lipids; however, the biological response to these LNPs remains understudied. To e...
Autores principales: | Radmand, Afsane, Lokugamage, Melissa P., Kim, Hyejin, Dobrowolski, Curtis, Zenhausern, Ryan, Loughrey, David, Huayamares, Sebastian G., Hatit, Marine Z. C., Ni, Huanzhen, Del Cid, Ada, Da Silva Sanchez, Alejandro J., Paunovska, Kalina, Schrader Echeverri, Elisa, Shajii, Aram, Peck, Hannah, Santangelo, Philip J., Dahlman, James E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912332/ https://www.ncbi.nlm.nih.gov/pubmed/36701517 http://dx.doi.org/10.1021/acs.nanolett.2c04479 |
Ejemplares similares
-
Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo
por: Ni, Huanzhen, et al.
Publicado: (2022) -
Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands
por: Gan, Zubao, et al.
Publicado: (2020) -
Drug delivery systems for RNA therapeutics
por: Paunovska, Kalina, et al.
Publicado: (2022) -
Increased PIP3 activity blocks nanoparticle mRNA delivery
por: Paunovska, Kalina, et al.
Publicado: (2020) -
Small interfering RNA–mediated allele-selective silencing of von Willebrand factor in vitro and in vivo
por: Jongejan, Yvonne K., et al.
Publicado: (2023)